the disease-free survival at 2 years after bmt was 58 +/- 19 % when a patient was transplanted for refractory anaemia ( ra ( s ] , 74 +/- 14 % for refractory anaemia with excess of blasts ( raeb ) , 50 +/- 16 % for raeb in transformation ( raebt ) , and 18 +/- 11 % for secondary aml .
C0002893
refractory anaemia
C0002894
raeb